1,034 results on '"Itoh, Kyogo"'
Search Results
302. Expression of a newly defined tumor-rejection antigen SART3 in musculoskeletal tumors and induction of HLA class I-restricted cytotoxic T lymphocytes by SART3-derived peptides
303. A Second Susceptibility Gene for Developing Rheumatoid Arthritis in the Human MHC Is Localized within a 70-kb Interval Telomeric of the TNF Genes in the HLA Class III Region
304. Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases
305. Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases
306. Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: A possible regulation of splicing by a complex formation
307. Interaction of the Hemolytic Lectin, CEL-III, with Cultured Human Leukemic Cell Lines
308. Expression of the SART1 tumor-rejection antigens in colorectal cancers
309. Expression of Tumor-rejection Antigens in Gynecologic Cancers
310. Expression of the SART3 Tumor-Rejection Antigen in Brain Tumors and Induction of Cytotoxic T Lymphocytes by Its Peptides
311. A polymorphism of the 5′ flanking region of tumour necrosis factor α gene is associated with thyroid-associated ophthalmopathy in Japanese
312. Induction of Human Leukocyte Antigen-A26–Restricted and Tumor-Specific Cytotoxic T Lymphocytes by a Single Peptide of the SART1 Antigen in Patients With Cancer With Different A26 Subtypes
313. Expression of SART3 Tumor-rejection Antigen in Gastric Cancers
314. Establishment and Epitope Analysis of Allo-Specific Cytotoxic T Lymphocytes at a Tumor Site Recognizing a Spouse's HLA-A0206 Molecule
315. Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTL
316. Biological Activities of the Lectin, Abrin-a, Against Human Lymphocytes and Cultured Leukemic Cell Lines
317. Mouse Homologue of the HumanSART3Gene Encoding Tumor-rejection Antigen
318. HLA-B35 and MICA-A5 synergistically enhanced the susceptibility to Chagas heart disease
319. Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes
320. PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer.
321. Expression of the tumor-rejection antigen SART1 in brain tumors
322. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5?-flanking region of the TNF? gene and HLA genes
323. A Cyclophilin B Gene Encodes Antigenic Epitopes Recognized by HLA-A24-Restricted and Tumor-Specific CTLs
324. Cytokines Required for Induction of Histocompatibility Leukocyte Antigen-class I-restricted and Tumor-specific Cytotoxic T Lymphocytes by a SART1-derived Peptide
325. Polymorphism of the 5′‐Flanking Region of the Tumor Necrosis Factor (TNF)–α Gene and Susceptibility to Human T‐Cell Lymphotropic Virus Type I (HTLV‐I) Uveitis
326. Analysis of tumor necrosis factor-alpha production and polymorphisms of the tumor necrosis factor-alpha gene in individuals with a history of Kawasaki disease
327. Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer
328. A newly identifiedMAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes
329. Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
330. Molecular Cloning of a Glycosylphosphatidylinositol-Anchored Molecule CDw108
331. Dominant Infiltration of TH 1-type CD4+T Cells at the Retrobulbar Space of Patients with Thyroid-Associated Ophthalmopathy
332. Expression of the SART-1 tumor rejection antigen in breast cancer
333. Expression of the SART-1 Antigens in Uterine Cancers
334. Sequence Analysis of Genes Encoding Rodent Homologues of the Human Tumor-rejection Antigen SART-1
335. A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes
336. Cytotoxicity Induced byErythrina variegataSerine Proteinase Inhibitors in Tumor Hematopoietic Stem Cell Lines
337. Histocompatibility Leukocyte Antigen-A2-restricted and Tumor-specific Cytotoxic T Lymphocytes from Tumor-infiltrating Lymphocytes of a Patient with Testicular Embryonal Cancer
338. Detection of MAGE-4 Protein in the Sera of Patients with Hepatitis-C Virus-associated Hepatocellular Carcinoma and Liver Cirrhosis
339. Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction
340. HLA-A2402-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Tumor-Infiltrating Lymphocytes of a Child with Wilms' Tumor
341. CD4+Hepatic Cancer-Specific Cytotoxic T Lymphocytes in Patients with Hepatocellular Carcinoma
342. HLA Class I-Restricted and Tumor-Specific Cytotoxic T Lymphocytes from Metastatic Lymph Nodes of Esophageal Cancers
343. β2-Integrin-Mediated Signal Up-Regulates Counterreceptor ICAM-1 Expression on Human Monocytic Cell Line THP-1 through Tyrosine Phosphorylation
344. Detection of MAGE‐4 Protein in Sera of Lung Cancer Patients
345. HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer
346. HLA-A Locus-Restricted and Tumor-Specific CTLs in Tumor-Infiltrating Lymphocytes of Patients with Non-Small Cell Lung Cancer
347. Histocompatibility Leukocyte Antigen‐A2402‐restricted Cytotoxic T Lymphocytes Recognizing Adenocarcinoma in Tumor‐infiltrating Lymphocytes of Patients with Colon Cancer
348. Detection of MAGE-4 protein in sera of patients with head-and-neck squamous-cell carcinoma
349. Development of Cancer Vaccine by Tumor Rejection Antigens
350. Expression of MAGE genes in colorectal carcinomas.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.